author-photo

Hans Jochem Kolb

Technische Universität München

19

Papers

179

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Abstract 2462: MondoA mediates in vivo aggressiveness of common ALL and may serve as a T-cell immunotherapy target

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (14)
Stem cell rescue from irradiation of multifocal bone disease combined with high-dose chemotherapy and reduced intensity conditioned haplodisparate stem cell transplantation in advanced pediatric sarcomas: Update of MetaEICESS 2007.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

2014 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (39)
The Vigor of Defense Against Non-Self: Potential Superiority of Allorestricted T Cells in Immunotherapy of Cancer?

2013 Frontiers in Oncology
- Stefan Burdach
- Hans Jochem Kolb
Show All
- Source
- Cite
- Save
Citations (8)
myeloid leukemia Drug treatment is superior to allografting as first-line therapy in chronic

2013
Show All
- Source
- Cite
- Save
Citations (0)
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse

2013 Haematologica
Show All
- Source
- Cite
- Save
Citations (30)
photopheresis for treatment of chronic graft-versus-host disease A multicenter prospective phase 2 randomized study of extracorporeal

2013
Show All
- Source
- Cite
- Save
Citations (0)
Mast cells and GVHD: old cells with a new role.

2013 Blood
- Hans Jochem Kolb
Show All
- Source
- Cite
- Save
Citations (3)
Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)